- Author:
Jun Haeng LEE
1
;
Jae G KIM
;
Hye Kyung JUNG
;
Jung Hoon KIM
;
Woo Kyoung JEONG
;
Tae Joo JEON
;
Joon Mee KIM
;
Young Il KIM
;
Keun Won RYU
;
Seong Ho KONG
;
Hyoung Il KIM
;
Hwoon Yong JUNG
;
Yong Sik KIM
;
Dae Young ZANG
;
Jae Yong CHO
;
Joon Oh PARK
;
Do Hoon LIM
;
Eun Sun JUNG
;
Hyeong Sik AHN
;
Hyun Jung KIM
Author Information
- Publication Type:Review ; English Abstract ; Practice Guideline
- Keywords: Stomach neoplasms; Guidelines
- MeSH: Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Chemoradiotherapy, Adjuvant; Endoscopy, Gastrointestinal; Endosonography; Evidence-Based Medicine; Follow-Up Studies; Gastrectomy; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Republic of Korea; Stomach Neoplasms/*diagnosis/pathology/therapy; Tomography, X-Ray Computed
- From:The Korean Journal of Gastroenterology 2014;63(2):66-81
- CountryRepublic of Korea
- Language:Korean
- Abstract: Although, gastric cancer is quite common in Korea, the treatment outcome is relatively favorable compared to that of Western countries. However, there is no Korean multidisciplinary guideline for gastric cancer and thus, a guideline adequate for domestic circumstances is required. Experts from related societies developed 22 recommendation statements for the diagnosis (n=9) and treatment (n=13) based on relevant key questions. Evidence levels based on systematic review of literatures were classified as five levels from A to E, and recommendation grades were classified as either strong or weak. The topics of this guideline cover diagnostic modalities (endoscopy, endoscopic ultrasound, radiologic diagnosis), treatment modalities (surgery, therapeutic endoscopy, chemotherapy, radiotherapy) and pathologic evaluation. External review of the guideline was conducted at the finalization phase.